A new clinical trial is underway to evaluate the impact of maternal sleep, lifestyle, and metabolic health on perinatal outcomes in women with gestational diabetes. This study, spearheaded by the University of Split School of Medicine and the University Hospital of Split, incorporates both home-based and inpatient glucose monitoring interventions, aiming to better understand their role in improving care for expectant mothers.
What is the study about?
This research focuses on gestational diabetes, a condition influencing glucose metabolism during pregnancy and posing risks for both mother and baby. The investigators aim to evaluate maternal sleep patterns, lifestyle factors, and metabolic health, exploring how these elements affect perinatal outcomes. By integrating detailed glucose monitoring methods, the study seeks to generate evidence for optimizing diabetes management during pregnancy.
What interventions are being tested?
Home-Based Glucose Monitoring
Participants are provided tools for self-monitoring of glucose levels in a home setting. This intervention promotes real-world data collection, offering insights into daily glucose fluctuations and their relation to lifestyle patterns.
Inpatient Glucose Monitoring
In controlled clinical environments, this method ensures precision and reliability in tracking the participants’ glucose levels. It allows a comparison with the home-based approach to assess differences in efficacy and patient outcomes.
Who is leading the research?
This trial is a collaborative effort between the University of Split School of Medicine and the University Hospital of Split. These leading institutions are known for their commitment to improving medical standards through academic and clinical innovations. Their combined expertise underpins the integrity and scientific rigor of the study.
FAQ
1. What is the purpose of this trial?
To evaluate how maternal sleep, lifestyle, and metabolic health influence pregnancy outcomes in gestational diabetes patients.
2. Who can participate in the study?
The trial targets expectant mothers diagnosed with gestational diabetes. Further eligibility criteria are detailed on the study page.
3. How are the interventions different?
Home-based glucose monitoring focuses on real-world data from self-measurement, while inpatient monitoring provides controlled, clinical measurements for comparison.
4. Why is this research important?
It could lead to tailored approaches for managing gestational diabetes, minimizing risks for both mothers and their babies.
Conclusion
This ongoing clinical trial highlights the need for advanced methodologies in addressing gestational diabetes. By studying how lifestyle and health patterns integrate with innovative glucose monitoring methods, the findings may guide safer, more effective prenatal care strategies. Stakeholders, including healthcare professionals and regulatory bodies, should monitor developments closely.
Disclaimer
This article is for informational purposes only and does not constitute legal or clinical advice. Readers should consult professional guidance for specific applications.
Announcement Line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07314944?term=medical+device